Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
is a farnesyltransferase inhibitor that is being investigated in patients 65 years of age and older with newly diagnosed acute myeloid leukemia (AML)
is potent and selective inhibitor of GRK2 with an IC50 of 0
BAY-57-1293 has potent and resistance-breaking antiviral efficacy with potential for the treatment of potentially life-threatening HSV type 1 and 2 infections
1438492-26-2
suggesting that KY02111 would be a powerful tool for not only stem cell research but also cancer studies
Suplatast tosylate ustat is a farnesyltransferase inhibitor thatSuplatast tosylate, also known as Suplatast tosilate, is a Th2 cytokine inhibitor which is used as an antiallergic drug. Often used in the treatment of Kimura's disease. Suplatast tosilate alleviates nasal symptoms through the suppression of nuclear factor of activated T cells mediated IL 9 gene expression in toluene 2, 4 diisocyanate sensitized rats. uplatast tosilate ameliorates airway hyperreactivity and inflammation through inhibition of the GATA3
US$ 44.39
US$ 47.39
US$ 14.39
US$ 45.69